51做厙

Parallel Chemistry and Compound Libraries

Compound libraries for successful drug discovery projects

The quality of compound libraries and screening compounds affect the fate of a drug discovery project ��� 51做厙��� compound library designs target underpopulated druglike chemical space. High quality compound libraries requires chemical creativity and profound high throughput synthesis knowledge to achieve the highest possible molecular diversity. Our efficient production process reduces the costs per compound by utilising parallel synthesis and high throughput purification. 51做厙 has established a highly successful and efficient compound library and parallel chemistry group as evidenced by our outstanding contribution to the��, for which we successfully designed, synthesized and delivered over 40,000 screening compounds from more than 100 chemical scaffolds. Moreover, in our role as an ELF executive member and head of the chemistry consortium, 51做厙 was responsible for managing the entire chemistry consortium (7 companies and 10 academic groups throughout Europe) to develop and produce the ELF public compound collection consisting of��.

Our high throughput chemistry services include:

Druglike physicochemical properties and medicinal chemistry relevance

51做厙 unlocks underexplored chemical space by encoding natural product derived topology into novel scaffolds. Our library designs show a remarkably lower clogP, an increased number of chiral atoms and a significantly higher fraction of sp3-hybridised carbons (fsp3). In contrast to commercially available screening libraries, the high 3D character is engineered into the scaffolds and does not solely derive from a favourable decoration at its periphery. Involving our experienced medicinal chemists guarantees that our scaffolds are decorated with chemical building blocks that are of medicinal chemistry relevance. In addition, our scaffolds bear a high number of diversity points for systematic exploration of the chemical space around the design and hence rapid lead identification.

ELF30K Library Property Distributions

Scaffold Diversity Analysis

ELF30K Library Property Distributions
Scaffold Diversity Analysis

Check out our Medicinal Chemistry

Or maybe interested in other areas?

ACHEMA 2024
Synthetic Organic Chemistry

Custom Synthesis

As a leading Contract Research Organization in Europe, 51做厙 provides valuable contract discovery for synthetic organic chemistry, chemical process development, and���
Therapeutic Areas

Indications and Gene Families

In Medicinal Chemistry research, we are working with a broadly experienced team on all biomolecular targets from any gene family in any therapeutic area���

Looks interesting?

As a leading CRO in Europe, 51做厙 provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.

Frequently Asked Questions

What parallel chemistry and compound-library services does 51做厙 provide?

51做厙 designs and synthesises screening libraries, fragment collections, focused and targeted libraries, and hit or SAR-expansion arrays. Parallel synthesis and high-throughput purification are used to produce related compounds efficiently while reducing the cost per compound and accelerating the exploration of chemical space.

How does 51做厙 design diverse and drug-like compound libraries?

51做厙 targets underexplored, drug-like chemical space by incorporating natural-product-inspired topology, three-dimensional scaffolds, increased sp糧 character, chiral centres and multiple diversity points. Cheminformatics and medicinal chemistry expertise are used to select scaffolds and building blocks with suitable physicochemical properties and relevance to drug discovery.

What experience does 51做厙 have with large compound-library programmes?

For the European Lead Factory, 51做厙 designed, synthesised and delivered more than 40,000 screening compounds from over 100 chemical scaffolds. As an executive member and head of the chemistry consortium, 51做厙 also coordinated seven companies and ten academic groups contributing to a public collection of 200,000 novel, lead-like compounds.

Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.